[Involvement of the complement cascade in severe forms of COVID-19]
- PMID: 33835019
- DOI: 10.1051/medsci/2021021
[Involvement of the complement cascade in severe forms of COVID-19]
Abstract
The complement system is an essential component of the innate immune system. Its excessive activation during COVID-19 contributes to cytokine storm, disease-specific endothelial inflammation (endotheliitis) and thrombosis that comes with the disease. Targeted therapies of complement inhibition in COVID-19, in particular blocking the C5a-C5aR1 axis have to be taken into account in the establishment of potential biomarkers and development of therapeutic strategies in the most severe forms of the disease.
Title: Implication de la cascade du complément dans les formes sévères de COVID-19.
Abstract: Le système du complément est un composant essentiel du système immunitaire inné. Son activation excessive au cours de la COVID-19 participe à l’orage cytokinique, à l’inflammation endothéliale (endothélite) et aux thromboses qui accompagnent la maladie. Bloquer le complément, notamment l’axe C5a-C5aR1, par des thérapies spécifiques représente un espoir thérapeutique dans les formes les plus sévères de la maladie.
© 2021 médecine/sciences – Inserm.
Similar articles
-
Complement cascade in severe forms of COVID-19: Recent advances in therapy.Eur J Immunol. 2021 Jul;51(7):1652-1659. doi: 10.1002/eji.202048959. Epub 2021 Apr 10. Eur J Immunol. 2021. PMID: 33738806 Free PMC article. Review.
-
Association of COVID-19 inflammation with activation of the C5a-C5aR1 axis.Nature. 2020 Dec;588(7836):146-150. doi: 10.1038/s41586-020-2600-6. Epub 2020 Jul 29. Nature. 2020. PMID: 32726800 Free PMC article.
-
A double edged-sword - The Complement System during SARS-CoV-2 infection.Life Sci. 2021 May 1;272:119245. doi: 10.1016/j.lfs.2021.119245. Epub 2021 Feb 17. Life Sci. 2021. PMID: 33609539 Free PMC article. Review.
-
Mini-Factor H Modulates Complement-Dependent IL-6 and IL-10 Release in an Immune Cell Culture (PBMC) Model: Potential Benefits Against Cytokine Storm.Front Immunol. 2021 Apr 28;12:642860. doi: 10.3389/fimmu.2021.642860. eCollection 2021. Front Immunol. 2021. PMID: 33995361 Free PMC article.
-
Interaction of the inflammatory response and megakaryocytes in COVID-19 infection.Exp Hematol. 2021 Dec;104:32-39. doi: 10.1016/j.exphem.2021.09.005. Epub 2021 Sep 23. Exp Hematol. 2021. PMID: 34563606 Free PMC article. Review. No abstract available.
References
-
- Fisher D, Heymann D. Q&A: The novel coronavirus outbreak causing COVID-19. BMC Med 2020; 18 : 57.
-
- Ziegler CGK, Allon SJ, Nyquist SK, et al. SARS-CoV-2 Receptor ACE2 is an interferon-stimulated gene in human airway epithelial cells and is detected in specific cell subsets across tissues. Cell 2020; 181 : 1016–35.e19.
-
- Hadjadj J, Yatim N, Barnabei L, et al. Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients. Science 2020; 369 : 718–24.
-
- Zhang Q, Bastard P, Liu Z, et al. Inborn errors of type I IFN immunity in patients with life-threatening COVID-19. Science 2020; 370 : eabd4570.
-
- Lee JS, Shin EC. The type I interferon response in COVID-19: implications for treatment. Nat Rev Immunol 2020; 20 : 585–6.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical